Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT02266030
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Registry
-
NCT02266030
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02266030. Randomized; no masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2016-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Cilostazol on Coronary Artery Stenosis and Plaque Characteristics in Patients With T2DM
- Acronym
- ESCAPE
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Cilostazol
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Seoul National University Bundang Hospital
Record details
- Record id
cardio:ct-nct02266030- Content hash
3da0977254bfaf7bdd2140c842db408544c13211b7b7d06eda4df654ff709be2